Clinical Evaluation of a New Dual-cure Universal Adhesive

September 26, 2025 updated by: Ivoclar Vivadent AG

Clinical Evaluation of a New Dual-cure Universal Adhesive for Indirect Restorative Treatment

The overall aim of this study is to evaluate the clinical performance and safety of the new dental dual-cure adhesive for luting indirect ceramic restorations (inlays and onlays). The primary aim is to determine the rate of postoperative hypersensitivity occurrence after using the new adhesive for the placement of indirect restorations. The secondary objective of this study is to assess the long-term clinical performance of the new adhesive in terms of marginal quality, retention/fracture rate of the ceramic restorations, and vitality/fracture rate of the restored teeth.

Study Overview

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Liechtenstein
      • Schaan, Liechtenstein, Liechtenstein, 9494
        • Ivoclar Vivadent AG

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: 18-65 years
  • Informed consent signed and understood by the subject
  • Indication for indirect restorations (inlay, onlay) in molar or premolar
  • The occlusal area of the restoration must cover at least 1/3 of the occlusal area of the tooth.
  • visual analogue scale (VAS)<4 (0=no pain, 10=maximum conceivable pain)
  • Max. 2 restorations per participant in different quadrants.
  • Vital tooth
  • Healthy periodontium, no active periodontitis
  • Contact with adjacent teeth (at least at one side) and opposing teeth present with at least one contact point.
  • Sufficient language skills

Exclusion Criteria:

  • Insufficient isolation
  • Participants with a proven allergy to one of the ingredients of the materials used
  • Participants with proven allergy to local anaesthetics
  • High caries activity/ poor oral hygiene
  • Participants with severe systemic diseases
  • Pregnancy
  • Tooth with irreversible pulpitis
  • Indication for direct pulp capping
  • Bleaching of teeth within the last 14 days
  • Usage of peroxide-based disinfectants within the last 14 days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: New dual-cure adhesive
The newly developed dual-cure adhesive will be used for the placement of indirect restorations.
The newly developed dual-cure adhesive will be used for the placement of indirect restorations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Hypersensitivity
Time Frame: 1 month
will be assessed according to FDI criteria (grade 1-5, lower scores mean a better outcome)
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fracture Rate
Time Frame: 5 years
will be assessed according to FDI criteria (grade 1-5, lower scores mean a better outcome)
5 years
Marginal Quality
Time Frame: 5 years
will be assessed according to FDI criteria (grade 1-5, lower scores mean a better outcome)
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2024

Primary Completion (Actual)

March 27, 2025

Study Completion (Estimated)

April 1, 2031

Study Registration Dates

First Submitted

September 24, 2024

First Submitted That Met QC Criteria

September 24, 2024

First Posted (Actual)

September 26, 2024

Study Record Updates

Last Update Posted (Estimated)

October 23, 2025

Last Update Submitted That Met QC Criteria

September 26, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • OTCS187092274

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caries, Dental

Clinical Trials on Placement of indirect dental restoration

Subscribe